Zummo Jacqueline

Chief R&D Officer at TARA

Sold, on record
$221k
Dollars the filings state
Form 4 sales
3
Latest Apr 8, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TARAProtara Therapeutics, Inc.Chief R&D Officer

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice TARANotice
    Mar 26, 2025 2025

    Filed to sell 21,224 shares ($97k)

    Zummo Jacqueline, Officer

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale TARARoutine
    Mar 26, 2025 same day

    Sold 21,224 shares at $4.53 ($96k)

    Zummo Jacqueline, Chf Scientific Operations Off

    10b5-1 planSold 17.7% of holdings ($544k position)98,861 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 4 sale TARANo plan
    Apr 1, 2026 +371 days

    Sold 22,598 shares at $5.26 ($119k)

    Zummo Jacqueline, Chief R&D Officer

    No 10b5-1 planSold 19.1% of holdings ($624k position)95,961 shares leftFiling

  4. 4 Form 4 sale TARANo plan
    Apr 8, 2026 +7 days

    Sold 1,134 shares at $5.40 ($6k)

    Zummo Jacqueline, Chief R&D Officer

    No 10b5-1 planSold 1.2% of holdings ($518k position)94,827 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Zummo Jacqueline
Source
Apr 8, 2026Apr 9, 2026TARAChief R&D OfficerForm 4 sale1,134$6k1.2%No planSEC
Apr 1, 2026Apr 2, 2026TARAChief R&D OfficerForm 4 sale22,598$119k19.1%No planSEC
Mar 26, 2025Mar 28, 2025TARAChf Scientific Operations OffForm 4 sale21,224$96k17.7%RoutineSEC
Mar 26, 2025Mar 26, 2025TARAOfficerForm 144 notice21,224$97kNoticeSEC